Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction

Sonia Jain1, Henry T Ting, Malcolm Bell

  • 1Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.

Insights

New or presumed new left bundle branch block (LBBB) in patients with suspected heart attacks often leads to overdiagnosis. While identifying a high-risk group, most patients with new LBBB are discharged with alternative diagnoses, not acute myocardial infarction.

Area of Science:

  • Cardiology
  • Electrocardiography
  • Emergency Medicine

Background:

  • New or presumed new left bundle branch block (LBBB) is sometimes equated with ST-segment elevation myocardial infarction (STEMI).
  • The clinical utility of new LBBB in contemporary practice for diagnosing acute myocardial infarction (AMI) is not well established.

Purpose of the Study:

  • To investigate the hypothesis that new LBBB in symptomatic patients frequently leads to an overdiagnosis of AMI.
  • To evaluate the frequency, clinical characteristics, and outcomes of patients with new LBBB suspected of having AMI.

Main Methods:

  • Retrospective analysis of 892 patients in the Mayo Clinic's STEMI network (July 2004–August 2009).
  • Evaluation of 36 patients with new LBBB, comparing them to 856 patients without LBBB.
  • Analysis of clinical characteristics, troponin levels, coronary angiographic findings, and outcomes.

Main Results:

  • Patients with new LBBB were older, had higher risk scores, and were less likely to undergo primary percutaneous coronary intervention.
  • Only 39% of patients with new LBBB had acute coronary syndromes (ACS), with 12 diagnosed with AMI.
  • Two-thirds of patients with new LBBB were discharged with non-AMI diagnoses (cardiac or noncardiac).
  • The Sgarbossa score showed low sensitivity (14%) but high specificity (100%) for diagnosing AMI in the presence of new LBBB.

Conclusions:

  • New LBBB in patients with suspected AMI identifies a high-risk subgroup, but AMI is infrequent.
  • The Sgarbossa criteria have limited clinical utility for diagnosing AMI in new LBBB due to low sensitivity.
  • A significant proportion of patients with new LBBB are discharged with alternative diagnoses, suggesting overdiagnosis of AMI.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...